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in-hospital mortality; careful selection of oxy-
gen saturation targets in clinical practice is also 
warranted.
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A Step-up Approach, or Open Necrosectomy for Necrotizing 
Pancreatitis
To the Editor: The results from the study by van 
Santvoort et al. (Minimally Invasive Step-up Ap-
proach versus Maximal Necrosectomy in Patients 
with Acute Necrotizing Pancreatitis [PANTER]) 
(April 22 issue)1 show that percutaneous drain-
age (PCD) alone is a valuable strategy in selected 
patients, helping to avoid the need for surgery in 
40% of step-up patients.
The reduced morbidity associated with the 
procedure may largely be due to the avoidance of 
harm from surgery: when PCD-only patients are 
not considered, the complication rate appears to 
be similar in the two study groups. Moreover, 
PCD was often inadequate, leading to a delay in 
source control. Since PCD appears to be less suc-
cessful in patients with multiple organ failure,2 
and since mortality dramatically increased when 
it was used as a sole strategy for these patients,3 
an important element of the treatment is poten-
tially delayed. Early identification of patients who 
will not be helped by PCD is desirable.
Rather than using a step-up approach for all 
patients, a strategy tailored to the patient’s spe-
cific needs, based on the results of computed 
tomography and on clinical condition, using the 
source-control strategy most likely to adequately 
drain collected fluid and débride infected ne-
crotic tissue may be the best approach after all. 
PCD, video-assisted retroperitoneal débridement, 
and open necrosectomy may all be effective tools 
to use in reaching this goal.
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To the Editor: The PANTER study group teaches 
us that “minimally” invasive surgery is associat-
ed with a lower morbidity than open necrosec-
tomy in patients who have necrotizing pancreati-
tis with infected necrotic tissue. Although this 
article is a milestone in the surgical literature, its 
results are disappointing. There was no signifi-
cant difference in the mortality of the two study 
groups (16% vs. 19%) despite the fact that inter-
vention was withheld for at least 4 weeks. The 
complications in the group receiving “minimal-
ly” invasive treatment included enterocutaneous 
fistulas (in 22% of patients), intra-abdominal 
bleeding (16%), pancreatic fistulas (28%), and in-
cisional hernias (7%).1 The surgery these patients 
received was clearly not “minimally” invasive.
But is there another approach? Does infected 
necrotic tissue need drainage at all? Several case 
reports and series have recorded reasonable sur-
vival rates among patients treated with antibiot-
ics alone.1-4 Now that withholding intervention 
for at least 4 weeks seems to be ensconced in 
good surgical practice, perhaps a longer wait, 
coupled with the judicious use of antibiotics, can 
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further reduce mortality and the need for any 
invasive intervention.
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The Authors Reply: We first want to clarify sev-
eral issues discussed by Dr. Andrew Warshaw in 
the editorial he wrote about our article.1 War-
shaw stated that the step-up approach has nar-
row applicability. This is not correct. The feasi-
bility of the step-up approach was 98%, with just 
one patient excluded because a drain could not 
be placed. Warshaw also stated that the feasibil-
ity of using a retroperitoneal access route was a 
criterion for inclusion in the trial. This was not 
the case: percutaneous or endoscopic catheter 
drainage of fluid could proceed through any 
route (retroperitoneal, transabdominal, or endo-
scopic transgastric). Nevertheless, a retroperito-
neal access route for drainage, and if needed, 
video-assisted retroperitoneal débridement, was 
possible in 80 of the 88 patients (91%) who un-
derwent randomization. It was also noted that 
the rate of death in our study (17%) compares 
unfavorably to rates in recent North American 
studies.2,3 This difference can probably be attri-
buted to differences in case mix, since these 
studies showed lower percentages of infected ne-
crotic tissue (72 to 74% vs. 92%) and lower pre-
operative scores on the Acute Physiology and 
Chronic Health Evaluation (APACHE) II (9.0 to 
9.5 vs. 15). Notably, in the Boston study refer-
enced by Warshaw, the rate of death among pa-
tients with infected necrotic tissue (i.e., the sub-
group similar to that in our study) was 15%.3
In his letter, De Waele suggests that PCD was 
often inadequate, leading to a delay in source 
control. However, we do not consider PCD to 
have failed when surgery is still needed. PCD is 
appreciated as a means of stabilizing sepsis and 
thereby improving the patient’s condition for sub-
sequent surgery. Basing his remarks on retro-
spective studies, De Waele also suggests that 
PCD is less successful in patients with multiple-
organ failure. In our study, PCD was successful 
in 35% of patients, irrespective of single or multi-
ple organ failure. It is also suggested that mor-
tality increases dramatically when PCD is used 
as a sole strategy. This was not the case in our 
study: the rate of death among patients undergo-
ing PCD only was 12% (2 patients of 17) as com-
pared with 23% (6 of 26) among those undergo-
ing PCD and surgery. We therefore conclude that 
PCD should be the first treatment whenever pos-
sible.
Steinberg suggests that the mortality rate in 
our study is disappointing. However, recent series 
from expert centers in Boston and Liverpool 
show similar mortality rates.3,4 We agree that a 
very small subgroup of patients with infected 
necrotic tissue might be treated with antibiotics 
alone, but this approach has been discussed only 
in case reports and very small series, and multi-
ple-organ failure still develops in these patients.5 
In our study, a nationwide multidisciplinary ex-
pert panel agreed on the indication for interven-
tion in each patient.
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